Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration

被引:3
|
作者
Kirkova, Radina [1 ,2 ]
Murgova, Snezhana [1 ,3 ]
Kirkov, Vidin [4 ]
Tanev, Ivan [5 ]
机构
[1] Med Univ Pleven, Dept Ophthalmol ENT & Maxillofacial Surg, Pleven 5800, Bulgaria
[2] IRCCS Humanitas Res Hosp, Dept Ophthalmol, I-20089 Rozzano, Italy
[3] Univ Hosp Dr Georgi Stranski, Dept Ophthalmol, Pleven 5800, Bulgaria
[4] Med Univ Sofia, Fac Publ Hlth Prof Dr Tzekomir Vodenicharov, Dept Hlth Policy & Management, Sofia 1000, Bulgaria
[5] Eye Clin Zrenie, Sofia 1000, Bulgaria
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 09期
关键词
OCT-A; neovascularization; AMD; anti-VEGF; vascular remodeling; personalized; approach; OPTICAL COHERENCE TOMOGRAPHY; VISUAL IMPAIRMENT; ANGIOGRAPHY; TYPE-1;
D O I
10.3390/jpm12091456
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Age-related macular degeneration (AMD) is a progressive, degenerative disease of the central retina. AMD is subdivided into "dry" (atrophic), "wet" (exudative), and neovascular (nAMD) forms. In recent years, the concepts about nAMD changed with the development of optical coherence tomography-angiography (OCT-A) and intravitreal anti-VEGF treatment. The aim of this study was to define the morphologic type of the neovascular membrane (NVM) before treatment with OCT-A and to register vascular remodeling after treatment with anti-VEGF. We also analyzed the relationship between NVM and visual acuity. Methods: The study was retrospective and included 119 patients with newly diagnosed, treatment-naive nAMD. All the patients underwent full ophthalmic examination and also fluoresceine angiography and optical coherence tomography-angiography (OCT-A). Results: Based on the collected data, we found repetitive regularities. Conclusion: The analysis of our results could be used as prognostic markers for the evolution of the disease and as a basis for new treatment strategies, depending on the naive NVM morphologic type.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Guidance for the treatment of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Richard, Gisbert
    Augustin, Albert
    Aylward, William G.
    Bandello, Francesco
    Corcostegui, Borja
    Cunha-Vaz, Jose
    Gaudric, Alain
    Leys, Anita
    Schlingemann, Rainier O.
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05): : 486 - 494
  • [2] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [3] TREATMENT PATTERNS OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Dugel, P. U.
    Arnold, R. J.
    Layton, A. J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A149 - A149
  • [4] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    [J]. DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [5] Advances in the treatment of neovascular age-related macular degeneration
    Lanzetta, Paolo
    [J]. EJHP PRACTICE, 2008, 14 (06): : 17 - 20
  • [6] Neovascular Age-Related Macular Degeneration
    Veritti, Daniele
    Sarao, Valentina
    Lanzetta, Paolo
    [J]. OPHTHALMOLOGICA, 2012, 227 : 11 - 20
  • [7] Prognosis and treatment of macular bleeding in neovascular age-related macular degeneration
    Agostini, H. T.
    Bopp, S.
    Feltgen, N.
    [J]. OPHTHALMOLOGE, 2017, 114 (05): : 476 - 480
  • [8] Macular translocation for neovascular age-related macular degeneration
    Eandi, Chiara M.
    Giansanti, Fabrizio
    Virgili, Gianni
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [9] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [10] Current advances in the treatment of neovascular age-related macular degeneration
    Villegas, Victor M.
    Aranguren, Luis A.
    Kovach, Jaclyn L.
    Schwartz, Stephen G.
    Flynn, Harry W., Jr.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (02) : 273 - 282